Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.bcp.2009.12.014
DC Field | Value | |
---|---|---|
dc.title | Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin | |
dc.contributor.author | Zhou, J. | |
dc.contributor.author | Ong, C.-N. | |
dc.contributor.author | Shen, H.-M. | |
dc.contributor.author | Hur, G.-M. | |
dc.date.accessioned | 2011-07-26T02:52:08Z | |
dc.date.available | 2011-07-26T02:52:08Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Zhou, J., Ong, C.-N., Shen, H.-M., Hur, G.-M. (2010). Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin. Biochemical Pharmacology 79 (9) : 1242-1250. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bcp.2009.12.014 | |
dc.identifier.issn | 00062952 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/24575 | |
dc.description.abstract | Andrographolide (Andro), a diterpenoid lactone isolated from a traditional herbal medicine Andrographis paniculata, is known to possess potent anti-inflammatory and anticancer properties. In this study, we sought to examine the effect of Andro on signal transducer and activator of transcription 3 (STAT3) pathway and evaluate whether suppression of STAT3 activity by Andro could sensitize cancer cells to a chemotherapeutic drug doxorubicin. First, we demonstrated that Andro is able to significantly suppress both constitutively activated and IL-6-induced STAT3 phosphorylation and subsequent nuclear translocation in cancer cells. Such inhibition is found to be achieved through suppression of Janus-activated kinase (JAK)1/2 and interaction between STAT3 and gp130. For understanding the biological significance of the inhibitory effect of Andro on STAT3, we next investigated the effect of Andro on doxorubicin-induced apoptosis in human cancer cells. In our study the constitutive activation level of STAT3 was found to be correlated to the resistance of cancer cells to doxorubicin-induced apoptosis. Both the short-term MTT assay and the long-term colony formation assay showed that Andro dramatically promoted doxorubicin-induced cell death in cancer cells, indicating that Andro enhances the sensitivity of cancer cells to doxorubicin mainly via STAT3 suppression. These observations thus reveal a novel anticancer function of Andro and suggest a potential therapeutic strategy of using Andro in combination with chemotherapeutic agents for treatment of cancer. © 2009 Elsevier Inc. All rights reserved. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.bcp.2009.12.014 | |
dc.source | Scopus | |
dc.subject | Andro | |
dc.subject | Apoptosis | |
dc.subject | Doxorubicin | |
dc.subject | STAT3 | |
dc.type | Article | |
dc.contributor.department | EPIDEMIOLOGY & PUBLIC HEALTH | |
dc.description.doi | 10.1016/j.bcp.2009.12.014 | |
dc.description.sourcetitle | Biochemical Pharmacology | |
dc.description.volume | 79 | |
dc.description.issue | 9 | |
dc.description.page | 1242-1250 | |
dc.identifier.isiut | 000275681900004 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.